Search
for
Sort by
Research 721–750 of 1000+
- Racial and Gender Influences on Skin Disease
- Androgenetska alopecija u žena
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Hirsutism: diagnosis and treatment
- Menopause, skin and common dermatoses. Part 2: skin disorders
- Clinical markers of androgenicity in acne vulgaris
- Current evaluation of amenorrhea
- Assessment, diagnosis and treatment of a patient with hirsutism
- Congenital adrenal hyperplasia
- Advances in Nanocarrier Systems for Dermatologic Transdermal Drug Delivery: A Chemical and Molecular Review
- PCOS and Obesity: Contraception Challenges
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Predictors of Scalp Hair Thinning in Women with Polycystic Ovary Syndrome
- Hormonal Therapy for Acne
- Understanding Polycystic Ovary Syndrome
- The Interrelation Between Hirsutism and Androgen Hormone Levels as Well as Serum TNFΑ Concentrations
- The Effect of Ferritin, Vitamin D, and Some Hormonal and Biochemical Parameters on Patients with Female-pattern Hair Loss after COVID-19 Infection
- External Validation of PCOS Questionnaire in Assessing Quality of Life in Females with PCOS Based on Lifestyle Changes with Therapeutic Measures like OC Pills and Metformin
- Skin Related Problems Among Women of Reproductive Age Suffering from Polycystic Ovarian
- Supraphysiological Dose of Testosterone Impairs the Expression and Distribution of Sex Steroid Receptors during Endometrial Receptivity Development in Female Sprague–Dawley Rats
- Dermatological considerations for transgender and gender diverse patients: An Australian perspective
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity